Nordic Bioscience Announces PRO-C3 Launched By Roche Diagnostics On Cobas Analysers
Nordic Bioscience's scientists have over that last 10 years published more than 250 scientific papers on PRO-C3 making us the leading place for research within PRO-C3 and fibrotic related diseases.
PRO-C3 is the first of the Nordic Bioscience-biomarkers from our fibrosis panel which has been CE-approved. 40% of deaths in the western world are associated with alterations of organs such as the liver, and we provide the tools to quantify this. These are the tools of modern clinical chemistry.
"The Elecsys PRO-C3 test is the first test launched from the collaboration between Nordic Bioscience and Roche Diagnostics. We are proud that our technology becomes globally available to make a difference for patients." said Morten Karsdal, CEO of Nordic Bioscience.
About PRO-C3
PRO-C3 was invented by Nordic Bioscience and has up until now been available as a service performed in Nordic Bioscience's laboratory in Denmark using the nordicPRO-C3TM test. The Elecsys PRO-C3 test is developed under a license agreement between Nordic Bioscience and Roche Diagnostics. For more information including scientific information on PRO-C3 see
About Nordic Bioscience
Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. We are engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting. For more information about Nordic Bioscience, visit us at
For product related inquires please use contact
Photo -
Logo -

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Excellion Finance Scales Market-Neutral Defi Strategies With Fordefi's MPC Wallet
- United States Lubricants Market Growth Opportunities & Share Dynamics 20252033
- Japan Skin Care Products Market Size Worth USD 11.6 Billion By 2033 CAGR: 4.18%
- Spycloud Launches Consumer Idlink Product To Empower Financial Institutions To Combat Fraud With Holistic Identity Intelligence
- Cartesian Launches First Outsourced Middle-Back-Office Offering For Digital Asset Funds
- United States Fin Fish Market Size Forecast With Demand Outlook 20252033
Comments
No comment